NCT00913341View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 30, 1991

Primary Completion Date

November 30, 1991

Study Completion Date

November 30, 1991

Conditions

Anxiety

Interventions

DRUG

Alprazolam Tablets, 1 mg (Geneva Pharmaceuticals)

DRUG

Alprazolam Tablets, 1 mg (The Upjohn Company)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY

NCT00913341 - To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg | Biotech Hunter | Biotech Hunter